XL418

XL418 Uses, Dosage, Side Effects, Food Interaction and all others data.

XL418 is a novel anticancer compound.

Trade Name XL418
Generic XL418
Type
Protein binding

XL418 is an inhibitor of protein kinase B (PKB or AKT) and S6 Kinase (S6K), key components of the phosphoinosotide-3 kinase (PI3K) signaling pathway.

Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
XL418
XL418

Uses

Cancer

How XL418 works

XL418 is a small molecule that inhibits the activity of protein kinase B (PKB or AKT) and S6 Kinase (S6K), which act downstream of phosphoinosotide-3 kinase (PI3K). Activation of these kinases is a frequent event in human tumors, promoting cell growth, survival, and resistance to chemotherapy and radiotherapy. Inactivation of the pathway through inhibition of AKT is expected to induce apoptosis (programmed cell death) in tumor cells. AKT inhibitors may also sensitize tumor cells to a wide range of chemotherapy.

Innovators Monograph

You find simplified version here XL418

*** Taking medicines without doctor's advice can cause long-term problems.
Share